Biotheranostics CancerTYPE ID aids in patient selection for immunotherapy
21 sept. 2020 08h00 HE
|
Biotheranostics, Inc.
San Diego, CA, Sept. 21, 2020 (GLOBE NEWSWIRE) -- Biotheranostics announces the publication of a new study evaluating CancerTYPE ID® and its role in identifying subsets of patients with Cancer of...